You are here

  • Home
  • Archive
  • Volume 10, Issue 4
  • Genetic characteristics involving the PD-1/PD-L1/L2 and CD73/A2aR axes and the immunosuppressive microenvironment in DLBCL

Article info

Article menu
Basic tumor immunology
Original research
Genetic characteristics involving the PD-1/PD-L1/L2 and CD73/A2aR axes and the immunosuppressive microenvironment in DLBCL

Authors

  • Tingting Zhang Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, the Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China PubMed articlesGoogle scholar articles
  • Hengqi Liu Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, the Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China PubMed articlesGoogle scholar articles
  • Lei Jiao Panovue Biological Technology Co., Ltd, Beijing, China PubMed articlesGoogle scholar articles
  • Zhenzhen Zhang Marvel Medical Laboratory, Tianjin Marvelbio Technology Co., Ltd, Tianjin, China PubMed articlesGoogle scholar articles
  • Jin He Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, the Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China PubMed articlesGoogle scholar articles
  • Lanfang Li Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, the Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China PubMed articlesGoogle scholar articles
  • Lihua Qiu Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, the Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China PubMed articlesGoogle scholar articles
  • Zhengzi Qian Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, the Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China PubMed articlesGoogle scholar articles
  • Shiyong Zhou Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, the Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China PubMed articlesGoogle scholar articles
  • Wenchen Gong Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China PubMed articlesGoogle scholar articles
  • Bin Meng Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China PubMed articlesGoogle scholar articles
  • Xiubao Ren Department of Immunology/Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China PubMed articlesGoogle scholar articles
  • Huilai Zhang Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, the Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China PubMed articlesGoogle scholar articles
  • Xianhuo Wang Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, the Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China PubMed articlesGoogle scholar articles

Citation

Zhang T, Liu H, Jiao L, et al
Genetic characteristics involving the PD-1/PD-L1/L2 and CD73/A2aR axes and the immunosuppressive microenvironment in DLBCL
Journal for ImmunoTherapy of Cancer 2022;10:e004114. doi: 10.1136/jitc-2021-004114
Online issue publication 
August 25, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.